Orchestra biomed's
WebJul 30, 2024 · Orchestra BioMed is a biomedical innovation company focused on developing transformative therapeutic products for large unmet needs in procedure-based medicine. WebOrchestra BioMed has a 52-week low of $7.49 and a 52-week high of $19.18. The medical device technology company went public via a special purpose acquisition company merger (SPAC) on Jan. 26...
Orchestra biomed's
Did you know?
WebMar 31, 2024 · Orchestra Biomed Hldgs Inc (OBIO) Try Excel Alerts Watch Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals See More Market Capitalization, $K 227,043 Shares Outstanding, K 11,212 Annual Sales, $ -782 K Annual Income, $ -2,740 K 60-Month Beta 0.33 Price/Sales 4,355.00 Price/Cash Flow N/A WebMar 7, 2024 · Orchestra BioMed (NASDAQ: OBIO) develops therapeutic products for large, unmet clinical needs in procedure-based medicine. It focuses on forging strategic …
WebMay 17, 2024 · Orchestra BioMed is a biomedical innovation company focused on developing transformative therapeutic products for large unmet needs in procedure-based medicine. The Company is led by a highly accomplished, multidisciplinary management team and board of directors with extensive experience in all phases of medical device … WebSep 20, 2024 · NEW HOPE, Pa., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed™, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies, today announced the presentation of positive long-term …
WebAug 17, 2024 · Orchestra BioMed is a biomedical innovation company focused on developing transformative therapeutic products for large unmet needs in procedure-based medicine. The Company is led by a highly accomplished, multidisciplinary management team and board of directors with extensive experience in all phases of medical device … WebPhone Number 917-254-4900. Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for …
WebSep 20, 2024 · NEW HOPE, Pa., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed™, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to...
WebJan 27, 2024 · Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading … grand crew filming locationsWebJul 6, 2024 · Orchestra BioMed Holdings is expected have a fully diluted pro forma market cap of $407 million and an enterprise value of $158 million. It will be led by David Hochman, the chairman, CEO and... grand crete mirabello bayWeb1 day ago · Industry: Medical - Biomedical and Genetics View All Zacks #1 Ranked Stocks Orchestra BioMed Holdings, Inc. (OBIO) Quote Overview » Zacks Research » Orchestra BioMed Holdings, Inc. (OBIO) Style ... grand crew nbc reviewWebMar 7, 2024 · Orchestra BioMed’s flagship product candidates include BackBeat Cardiac Neuromodulation Therapy for the treatment of hypertension and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of certain forms of artery disease. The company was founded in 2024 and is based in New Hope, Pennsylvania. grand crew hatteras realtychinese buffet florida city flWebOrchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine. New Hope, Pennsylvania, United States 11-50 www.orchestrabiomed.com/ 2,061 Highlights Stock Symbol NASDAQ:OBIO Investments 1 Total Funding Amount $282.8M Employee Profiles 6 Contacts 13 Investors 8 grand crew nbc castWebOrchestra BioMed’s partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global … grand crew nbc wiki